Skip to main content
. 2018 Nov 24;63(3):563–572. doi: 10.1007/s12020-018-1792-0

Table 3.

Treatments before pegvisomant start

Diabetes (n = 510) No-diabetes (n = 1,252) All (n = 1,762) P-value
Medical treatment only 103 (20.2%) 185 (14.8%) 288 (16.3%)  < 0.01
Surgery only 21 (4.1%) 50 (4.0%) 71 (4.0%) NS
Radiotherapy only 0 1 (0.1%) 1 (0.1%) NA
Medical treatment and surgery 212 (41.6%) 626 (50.0%) 838 (47.6%) < 0.01
Medical treatment and radiotherapy 16 (3.1%) 24 (1.9%) 40 (2.3%) NS
Surgery and radiotherapy 12 (2.4%) 21 (1.7%) 33 (1.9%) NS
Medical treatment, surgery and radiotherapy 126 (24.7%) 293 (23.4%) 419 (23.8%) NS

NA not available, NS not significant